Showing results (391-400 of 424) with videos related to

Sort By:
Pageof 43
Biochemical and Biophysical Research Communications|November 4, 2022
Acid-induced disassembly of the Haemophilus ducreyi cytolethal distending toxinG Robb Huhn, Celine Sparkes, Isabel Silva, et al.
Translational Stroke Research|February 23, 2020
Modeling Mixed Vascular and Alzheimer's Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic MiceEric Y Hayden, Julia M Huang, Malena Charreton, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactionsEmmy Li, Camila Benitez, Steven C Boggess, et al.
Archives of Neurology|April 15, 2009
Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluidQiu-Lan Ma, Douglas R Galasko, John M Ringman, et al.
Frontiers in Microbiology|March 7, 2022
Murine Model for Measuring Effects of Humanized-Dosing of Antibiotics on the Gut MicrobiomeShana R Leopold, Kamilia Abdelraouf, David P Nicolau, et al.
International Journal of MS Care|December 23, 2017
Fatigue and Mood States in Nursing Home and Nonambulatory Home-Based Patients with Multiple SclerosisZilfah Younus, Caila B Vaughn, Shaik Ahmed Sanai, et al.
Psychiatry|March 14, 2018
Patient-Centered Care Transitions After Injury Hospitalization: A Comparative Effectiveness TrialDouglas Zatzick, Joan Russo, Peter Thomas, et al.
The Journal of Biological Chemistry|December 25, 2012
Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic miceQiu-Lan Ma, Xiaohong Zuo, Fusheng Yang, et al.
Endokrynologia Polska|February 19, 2009
[The role of bone metabolic markers in qualification for treatment of osteoporosis. Results of POMOST study]Jerzy Przedlacki, Zbigniew Bartoszewicz, Krystyna Ksiezopolska-Orłowska, et al.
Pageof 43